What this program funds
The R21 supports early-stage, exploratory work: novel ideas, high-risk high-reward directions, new methods or models, and pilot studies that could open a field — not scaled-down versions of mature projects. Awards run up to two years and $275,000 in total direct costs, and the mechanism is not renewable: the intended exit is an R01 built on what the R21 revealed.
Eligibility in plain English
- Same broad PI eligibility as the R01: any independent investigator whose institution can support the work, at any career stage.
- Not every NIH institute accepts the parent R21, and several run their own R21 announcements with different priorities — check which institutes participate before assuming yours does.
- Preliminary data are not required, which is the point of the mechanism — though nothing forbids including what you have.
- Confirm specifics with your sponsored-programs office and the current funding opportunity announcement.
What you'll need to submit
- Specific Aims (1 page).
- Research Strategy (6 pages) — half the R01 length; ruthless economy required.
- Biographical Sketches (via SciENcv, up to 5 pages each).
- Budget and Justification respecting the $275,000/2-year and $200,000-per-year limits.
- Data Management and Sharing Plan.
- Facilities & Other Resources, Equipment, and — as applicable — the PHS Human Subjects and Clinical Trials Information form, Vertebrate Animals section, and Authentication of Key Resources.
- Letters of support from collaborators.
Tips for this mechanism
- An R21 is not a small R01, and reviewers punish the confusion. If your project has solid preliminary data and an incremental design, it will be criticized as "should have been an R01." Lead with novelty and what the field gains if the risk pays off.
- Do the math before defaulting to it as the "easier" grant. At many institutes R21 success rates are no better than R01 rates, the money is a fraction, and it is not renewable. Choose it because the science is exploratory, not because it feels safer.
- Design for a two-year exit. Reviewers ask what happens at the end; the strongest R21s state explicitly which R01-ready result the two years will produce, and how you'll know if the idea failed.
Related programs
- NIH R01 (when the project is mature enough for preliminary-data review)
- NIH R03 (small, low-risk, self-contained projects)
- NIH R33 and phased R21/R33 announcements at some institutes
- NIH DP2 New Innovator Award (high-risk research programs, early-career)